{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:50:57Z","timestamp":1777783857950,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00417-014-2637-z","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T02:19:15Z","timestamp":1399342755000},"page":"1001-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Long-term progression of retinal vasculitis in Beh\u00e7et patients using a fluorescein angiography scoring system"],"prefix":"10.1007","volume":"252","author":[{"given":"Hae Min","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"2637_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","volume":"27","author":"CM Deuter","year":"2008","unstructured":"Deuter CM, K\u00f6tter I, Wallace GR, Murray PI, St\u00fcbiger N, Zierhut M (2008) Beh\u00e7et\u2019s disease: ocular effects and treatment. Prog Retin Eye Res 27:111\u2013136","journal-title":"Prog Retin Eye Res"},{"key":"2637_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0039-6257(97)00026-X","volume":"42","author":"RK George","year":"1997","unstructured":"George RK, Chan C, Whitcup SM, Nussenblatt RB (1997) Ocular immunopathology of Beh\u00e7et\u2019s disease. Surv Ophthalmol 42:157\u2013162","journal-title":"Surv Ophthalmol"},{"key":"2637_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-197505000-00001","volume":"54","author":"T Chajek","year":"1975","unstructured":"Chajek T, Fainaru M (1975) Beh\u00e7et\u2019s disease. Report of 41 cases and a review of the literature. Medicine 54:179\u2013196","journal-title":"Medicine"},{"key":"2637_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/pmj.76.900.629","volume":"76","author":"V Kontogianis","year":"2000","unstructured":"Kontogianis V, Powell RJ (2000) Beh\u00e7et\u2019s disease. Postgrad Med J 76:629\u2013637","journal-title":"Postgrad Med J"},{"key":"2637_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-4362.1984.tb05658.x","volume":"23","author":"RC Wong","year":"1984","unstructured":"Wong RC, Ellis CN, Diaz LA (1984) Beh\u00e7et\u2019s disease. Int J Dermatol 23:25\u201332","journal-title":"Int J Dermatol"},{"key":"2637_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713689008999414","volume":"9","author":"MD Llopis","year":"1990","unstructured":"Llopis MD, Cervera M, Menezo JL (1990) Cyclosporin A treatment of Beh\u00e7et\u2019s disease: a long term study. Curr Eye Res 9:17\u201323","journal-title":"Curr Eye Res"},{"key":"2637_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","volume":"50","author":"C Evereklioglu","year":"2005","unstructured":"Evereklioglu C (2005) Current concepts in the etiology and treatment of Beh\u00e7et\u2019s disease. Surv Ophthalmol 50:297\u2013350","journal-title":"Surv Ophthalmol"},{"key":"2637_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02169409","volume":"227","author":"LS Atmaca","year":"1989","unstructured":"Atmaca LS (1989) Fundus changes associated with Beh\u00e7et\u2019s disease. Graefes\u2019s Arch Clin Exp Ophthalmol 227:340\u2013344","journal-title":"Graefes\u2019s Arch Clin Exp Ophthalmol"},{"key":"2637_CR9","first-page":"321","volume":"25","author":"LS Atmaca","year":"1994","unstructured":"Atmaca LS, Batioglu F (1994) The efficacy of cyclosporine A in the treatment of Beh\u00e7et\u2019s disease. Ophthalmic Surg 25:321\u2013327","journal-title":"Ophthalmic Surg"},{"key":"2637_CR10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/112067210201200514","volume":"12","author":"PC Ozdal","year":"2001","unstructured":"Ozdal PC, Orta\u00e7 S, Ta\u015fkintuna I, Ta\u015fkintuna I, Firat E (2001) Posterior segment involvement in ocular Beh\u00e7et\u2019s disease. Eur J Ophthalmol 12:424\u2013431","journal-title":"Eur J Ophthalmol"},{"key":"2637_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","volume":"4","author":"A Altenburg","year":"2006","unstructured":"Altenburg A, Papoustis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades\u2013Beh\u00e7et\u2019s disease in Germany\u2014current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49\u201364","journal-title":"J Dtsch Dermatol Ges"},{"key":"2637_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdo\u011fan H, Serdaro\u011flu S, Ersanli M, Ulk\u00fc BY, M\u00fcft\u00fco\u011flu AU (1984) Influence of age of onset and patient\u2019s sex on prevalence and severity of manifestations of Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 43:783\u2013789","journal-title":"Ann Rheum Dis"},{"key":"2637_CR13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","volume":"42","author":"H Yazici","year":"1991","unstructured":"Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Beh\u00e7et\u2019s syndrome. Drugs 42:796\u2013804","journal-title":"Drugs"},{"key":"2637_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"D Ben-Ezra","year":"1986","unstructured":"Ben-Ezra D, Cohen E (1986) Treatment and visual prognosis in Beh\u00e7et\u2019s disease. Br J Ophthalmol 70:589\u2013592","journal-title":"Br J Ophthalmol"},{"key":"2637_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Beh\u00e7et\u2019s disease: an analysis of 880 patients. Am J Ophthalmol 138:373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"2637_CR16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bjo.87.12.1466","volume":"87","author":"LS Atmaca","year":"2003","unstructured":"Atmaca LS, Sonmez PA (2003) Fluorescein and indocyanine green angiography findings in Beh\u00e7et\u2019s disease. Br J Ophthalmol 87:1466\u20131468","journal-title":"Br J Ophthalmol"},{"key":"2637_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09273940490518757","volume":"13","author":"S Gedik","year":"2005","unstructured":"Gedik S, Akova Y, Yilmaz G, Bozbeyo\u011flu S (2005) Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Beh\u00e7et\u2019s disease. Ocular Immunol Inflamm 13:51\u201358","journal-title":"Ocular Immunol Inflamm"},{"key":"2637_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/09273940802553279","volume":"17","author":"HG Yu","year":"2009","unstructured":"Yu HG, Kim MJ, Oh FS (2009) Fluorescein angiography and visual acuity in active uveitis with Beh\u00e7et\u2019s disease. Ocular Immunol Inflamm 17:41\u201346","journal-title":"Ocular Immunol Inflamm"},{"key":"2637_CR19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10792-008-9263-x","volume":"30","author":"I Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun I, Herbort CP, Khairallah M, The Angiography Scoring for Uveitis Working Group (ASUWOG) (2010) Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 30:539\u2013553","journal-title":"Int Ophthalmol"},{"key":"2637_CR20","first-page":"1078","volume":"1335","author":"The International Study Group for Beh\u00e7et\u2019s disease","year":"1990","unstructured":"The International Study Group for Beh\u00e7et\u2019s disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 1335:1078\u20131080","journal-title":"Lancet"},{"key":"2637_CR21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, The Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"2637_CR22","first-page":"73","volume-title":"Understanding fluorescein angiography","author":"M Spitznas","year":"2006","unstructured":"Spitznas M (2006) Understanding fluorescein angiography. Springer, Berlin, pp 73\u201399"},{"key":"2637_CR23","first-page":"42","volume-title":"Uveitis: fundamentals and clinical practice","author":"R Nussenblatt","year":"2010","unstructured":"Nussenblatt R (2010) Uveitis: fundamentals and clinical practice, 4th edn. Elsevier, Philadelphia, pp 42\u201371","edition":"4"},{"key":"2637_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","volume":"128","author":"DH Verity","year":"1999","unstructured":"Verity DH, Vaughan RW, Madanat W, Kondeatis E, Zureikat H, Fayyad F, Kanawati CA, Ayesh I, Stanford MR, Wallace GR (1999) Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et\u2019s disease. Am J Ophthalmol 128:352\u2013356","journal-title":"Am J Ophthalmol"},{"key":"2637_CR25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00417-005-0005-8","volume":"243","author":"M Takeuchi","year":"2005","unstructured":"Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai J, Usui M (2005) Risk and prognostic factors of poor visual outcome in Beh\u00e7et\u2019s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243:1147\u20131152","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2637_CR26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ajo.2008.08.038","volume":"146","author":"J Gueudry","year":"2008","unstructured":"Gueudry J, Wechsler B, Terrada C, Gendron G, Cassoux N, Fardeau C, Lehoang P, Piette JC, Bodaghi B (2008) Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Beh\u00e7et disease. Am J Ophthalmol 146:837\u2013844","journal-title":"Am J Ophthalmol"},{"key":"2637_CR27","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/art.27581","volume":"62","author":"CM Deuter","year":"2010","unstructured":"Deuter CM, Zierhut M, M\u00f6hle A, Vonthein R, St\u00f6biger N, K\u00f6tter I (2010) Long-term remission after cessation of interferon-\u03b1 treatment in patients with severe uveitis due to Beh\u00e7et\u2019s disease. Arthritis Rheum 62:2796\u20132805","journal-title":"Arthritis Rheum"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2637-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2637-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2637-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:40:23Z","timestamp":1565419223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2637-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2637"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2637-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}